Mina M Rizk1, Hanga Galfalvy2, Tanya Singh3, John G Keilp4, M Elizabeth Sublette4, Maria A Oquendo5, J John Mann6, Barbara Stanley4. 1. Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University, New York, NY, United States; Department of Psychiatry, Faculty of Medicine, Minia University, Egypt. Electronic address: rizkmin@nyspi.columbia.edu. 2. Department of Psychiatry, Columbia University, New York, NY, United States; Division of Biostatistics, New York State Psychiatric Institute, New York, NY, United States. 3. Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, United States. 4. Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University, New York, NY, United States. 5. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, PA, United States. 6. Molecular Imaging and Neuropathology Division, New York State Psychiatric Institute, New York, NY, United States; Department of Psychiatry, Columbia University, New York, NY, United States; Department of Radiology, Columbia University, New York, NY, United States.
Abstract
BACKGROUND: Suicide is a heterogeneous phenomenon, and thus defining more homogeneous subgroups may help in understanding its underlying biology and ultimately in its prevention. Suicidal ideation is far more common than suicidal behavior and predicts future suicide attempts. Hypothalamic-pituitary-adrenal (HPA)-axis reactivity has been implicated in individuals with suicidal ideation but findings are mixed with some studies showing increased and others demonstrating decreased reactivity. This suggests that dysregulation of HPA-axis is related to a specific character of suicidal ideation. We hypothesized that individuals with brief suicidal ideation are more stress responsive than those with longer/continuous ideation. METHODS: Thirty-five individuals with major depressive disorder (MDD) and 23 healthy volunteers (HVs), aged 18-65 years, underwent the Trier Social Stress Test (TSST). Salivary cortisol was measured at 6 time-points before and during TSST. Total severity and duration of current suicidal ideation were assessed using the Beck Scale for Suicidal Ideation (SSI). Brief suicidal ideators (N = 18), longer/continuous ideators (N = 17) and HVs were compared regarding cortisol response, baseline cortisol and total output. RESULTS: Participants with brief suicidal ideation had greater cortisol response compared to those with longer/continuous ideation and HVs, even after controlling for relevant covariates. However, total SSI score was not associated with cortisol response. Baseline cortisol and total output were not related to overall severity or duration of suicidal ideation. LIMITATIONS: The cross-sectional design and modest sample limit generalizability of the results. CONCLUSIONS: Hyper-responsiveness of HPA-axis to social stress is associated with brief suicidal ideation, possibly defining a pathway for exploring the biological subtyping of suicidal individuals.
BACKGROUND: Suicide is a heterogeneous phenomenon, and thus defining more homogeneous subgroups may help in understanding its underlying biology and ultimately in its prevention. Suicidal ideation is far more common than suicidal behavior and predicts future suicide attempts. Hypothalamic-pituitary-adrenal (HPA)-axis reactivity has been implicated in individuals with suicidal ideation but findings are mixed with some studies showing increased and others demonstrating decreased reactivity. This suggests that dysregulation of HPA-axis is related to a specific character of suicidal ideation. We hypothesized that individuals with brief suicidal ideation are more stress responsive than those with longer/continuous ideation. METHODS: Thirty-five individuals with major depressive disorder (MDD) and 23 healthy volunteers (HVs), aged 18-65 years, underwent the Trier Social Stress Test (TSST). Salivary cortisol was measured at 6 time-points before and during TSST. Total severity and duration of current suicidal ideation were assessed using the Beck Scale for Suicidal Ideation (SSI). Brief suicidal ideators (N = 18), longer/continuous ideators (N = 17) and HVs were compared regarding cortisol response, baseline cortisol and total output. RESULTS:Participants with brief suicidal ideation had greater cortisol response compared to those with longer/continuous ideation and HVs, even after controlling for relevant covariates. However, total SSI score was not associated with cortisol response. Baseline cortisol and total output were not related to overall severity or duration of suicidal ideation. LIMITATIONS: The cross-sectional design and modest sample limit generalizability of the results. CONCLUSIONS:Hyper-responsiveness of HPA-axis to social stress is associated with brief suicidal ideation, possibly defining a pathway for exploring the biological subtyping of suicidal individuals.
Authors: Scott T Wilson; Megan Chesin; Eric Fertuck; John Keilp; Beth Brodsky; J John Mann; Cemile Ceren Sönmez; Christopher Benjamin-Phillips; Barbara Stanley Journal: Psychiatry Res Date: 2016-04-16 Impact factor: 3.222
Authors: Konstantinos N Fountoulakis; Apostolos Iacovides; Fotis Fotiou; John Nimatoudis; Fransesca Bascialla; Christina Ioannidou; George Kaprinis; Per Bech Journal: Neuropsychobiology Date: 2004 Impact factor: 2.328
Authors: C R Pfeffer; G L Klerman; S W Hurt; T Kakuma; J R Peskin; C A Siefker Journal: J Am Acad Child Adolesc Psychiatry Date: 1993-01 Impact factor: 8.829
Authors: Leslie A Brick; Marisa E Marraccini; Lauren Micalizzi; Chelsie E Benca-Bachman; Valerie S Knopik; Rohan H C Palmer Journal: J Affect Disord Date: 2019-02-06 Impact factor: 4.839
Authors: Mina M Rizk; Tse-Hwei Choo; Hanga Galfalvy; Emily Biggs; Beth S Brodsky; Maria A Oquendo; J John Mann; Barbara Stanley Journal: Psychiatry Date: 2019-04-23 Impact factor: 2.458
Authors: Jenessa N Johnston; Darcy Campbell; Hector J Caruncho; Ioline D Henter; Elizabeth D Ballard; Carlos A Zarate Journal: Int J Neuropsychopharmacol Date: 2022-03-17 Impact factor: 5.176
Authors: Juliana Surjan; Julia Diniz Grossi; José Alberto Del Porto; Rodrigo Simonini Delfino; Raphael de Oliveira Cerqueira; Ana Cecília Lucchese; Eduardo Magalhães; Lorena Catarina Del Sant; Marco Aurélio Tuena; Carolina Nakahira; Victor Augusto Rodovalho Fava; Matheus Souza Steglich; Guilherme Lozi Abdo; Matheus Ghossain Barbosa; Luciana Maria Sarin; Acioly Luiz Tavares Lacerda Journal: Clin Drug Investig Date: 2022-08-31 Impact factor: 3.580
Authors: Barbara Stanley; Christina A Michel; Hanga C Galfalvy; John G Keilp; Mina M Rizk; Randall Richardson-Vejlgaard; Maria A Oquendo; J John Mann Journal: Psychiatry Res Date: 2019-07-16 Impact factor: 3.222
Authors: Raffaella Calati; Charles B Nemeroff; Jorge Lopez-Castroman; Lisa J Cohen; Igor Galynker Journal: Int J Neuropsychopharmacol Date: 2020-04-21 Impact factor: 5.176